Jason Rupp joins the Acclinate team

Jason brings 20 years of experience to lead Acclinate’s business development.

January 20, 2022 (Huntsville, Alabama) – Acclinate hires Jason Rupp as Head of Business Development effective January 20, 2022. Rupp brings nearly 20 years of business development experience to the company.

Before joining Acclinate, Rupp was President of Southeast Life Sciences (SLS), a trade association dedicated to supporting the life science community in the southeast. Among his many accomplishments at SLS, Rupp led the launch of SE Color, a division of SLS dedicated to advancing the issue of lack of diversity in clinical trials. Prior to his tenure at SLS, Rupp led business development for the Biotechnology Innovation Organization (BIO) and AdvaMed in Washington, DC.

Acclinate is committed to health equity through inclusive research. The addition of Rupp will ensure fairness in clinical trials that leads to better science and creates the potential to reduce health disparities. “Since launching the Diversity& Inclusion initiatives at SLS, I’ve learned the critical need to diversify our clinical trials,” Rupp said, “The opportunity to help address this need at Acclinate is truly an honor.”

“Jason’s business development experience, industry connections, and demonstrated focus on clinical trial diversity make him an ideal addition to our growing team,” said Del Smith, Acclinate’s CEO and co-founder.

Mr. Rupp has a master’s in business administration from the University of Maryland and a bachelor’s in political science from Brigham Young University.


About Acclinate™

Acclinate™ is a Birmingham-based, digital health company helping pharmaceutical companies and healthcare organizations access and engage communities of color so research is more inclusive.